Further special fields of analytics where we work are:

  • THC-Analytics

    Based on a  pdfSpecial Exemption Licence from the Swiss Federal Office of Public Health (FOPH / BAG), we are permitted to analyse a wide range of products for THC and THC derivatives.
    For example, we routinely carry out a content determination for tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) in our labs.
    Here, the THC-CBD ratio is often of special interest.

  • Steroid Analytics

    The subject of steroids remains very delicate: The use and or possession of steroids are forbidden in many countries, and they are frequently abused for doping. There are many dubious suppliers, which introduce poor quality or even fraudulently labelled products to the market. 
    In Switzerland, steroids analytics and the importation and possession of corresponding reference standards is permitted by the authorities. 

    Over the years, we have established the determination for a large number of very different steroids in our laboratory, but new products are constantly being introduced. While doing so, we were able to uncover false information about the content or ingredients several times and thus contribute to the prevention of further serious harm to the health of users.

 

If there are any doubts about the authenticity of a report of Simec AG, please contact us via info@simec.ch (please include a scan of the report).

We point out that original reports of Simec AG are only allowed to be published in complete und unmodified form. Further informations can be found on the "comments"-part of a report.

 

Important notice:

Fake reports of Simec AG have been published on the following pages, corresponding measures on our part have been initiated:

syncom-labs.com (website closed)

www.elite-labs.net

www.sigma-pharma.com (fake reports have been removed)

http://sarmscombo.com (fake reports have been removed)

bigpharma.store (website closed)

www.vogellabor.com (fake reports have been removed)

 

Please feel free to contact us if you have any further questions or comments.